OCUP - Ocuphire Pharma to Participate in Three Upcoming Investment Bank Conferences | Benzinga
FARMINGTON HILLS, Mich., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced that company management will be participating in one-on-one meetings at the H.C. Wainwright 25th Annual Global Investment Conference being held in New York City on September 11-13, 2023. Additionally, Ronil Patel, MS, Ocuphire's SVP of Operations & Business Development, will be participating in panel presentations at both the Cantor Annual Global Healthcare Conference being held in New York City on September 26-28, 2023 and the Inaugural Jones Trading 2023 Healthcare Summit being held in Miami Beach on October 9-11, 2023.
Cantor Annual Global Healthcare Conference – September 26-28, 2023
| Title: |
| Ocuphire Pharma, Inc. (OCUP) & Outlook Therapeutics, Inc. (OTLK) Panel Presentation |
| Presenter: |
| Ronil Patel, MS, SVP of Operations & Business Development |
| Date: |
| Tuesday, September 26, 2023 |
| Time: |
| 1:35 – 2:05pm ET in Track 1 |
JonesTrading 2023 Healthcare Summit – October 9-11, 2023
| Title: |
| All About Eyes – Paradigm Shifting Therapeutic Innovations in Ophthalmology (Panel 4) |
| Presenter: |
| Ronil Patel, MS, SVP of Operations & Business Development |
| Date: |
| Tuesday, October 10, 2023 |
| Time: |
| 1:45 PM – 2:30 PM ET |
If you are interested in arranging a 1x1 meeting, please contact your respective conference representative or ir@ocuphire.com. For more details, please see the Investors and Events section of Ocuphire's corporate website.
About Ocuphire Pharma
Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and ...